GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.24 $2.30 Friday, 19th Apr 2024 ATOS stock ended at $1.37. This is 3.52% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 7.52% from a day low at $1.33 to a day high of $1.43.
90 days $0.774 $2.30
52 weeks $0.590 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
2023-05-26 $0.90 $1.02 $0.85 $0.87 1 616 266
2023-05-25 $0.89 $1.02 $0.87 $0.97 2 941 423
2023-05-24 $0.84 $0.89 $0.799 $0.87 1 066 601
2023-05-23 $0.730 $0.88 $0.730 $0.84 3 094 654
2023-05-22 $0.725 $0.740 $0.720 $0.729 336 908
2023-05-19 $0.710 $0.730 $0.710 $0.727 444 197
2023-05-18 $0.701 $0.720 $0.700 $0.713 273 297
2023-05-17 $0.713 $0.715 $0.700 $0.710 378 321
2023-05-16 $0.700 $0.715 $0.700 $0.713 320 246
2023-05-15 $0.685 $0.710 $0.685 $0.707 270 109
2023-05-12 $0.683 $0.710 $0.683 $0.705 221 375
2023-05-11 $0.690 $0.700 $0.680 $0.684 308 247
2023-05-10 $0.720 $0.720 $0.675 $0.680 221 490
2023-05-09 $0.686 $0.748 $0.678 $0.720 565 930
2023-05-08 $0.720 $0.725 $0.673 $0.700 301 522
2023-05-05 $0.690 $0.699 $0.659 $0.686 286 771
2023-05-04 $0.650 $0.680 $0.625 $0.677 339 550
2023-05-03 $0.650 $0.699 $0.625 $0.662 483 150
2023-05-02 $0.640 $0.640 $0.600 $0.640 310 101
2023-05-01 $0.649 $0.650 $0.600 $0.600 219 326
2023-04-28 $0.634 $0.649 $0.630 $0.639 185 307
2023-04-27 $0.610 $0.650 $0.590 $0.634 404 475
2023-04-26 $0.620 $0.647 $0.600 $0.605 269 294
2023-04-25 $0.670 $0.672 $0.623 $0.635 582 884
2023-04-24 $0.694 $0.720 $0.663 $0.672 488 129
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT